Evaluation of Semen Self-Sampling Yield Predictors and CTC Isolation by Multi-Color Flow Cytometry for Liquid Biopsy of Localized Prostate Cancer
暂无分享,去创建一个
S. Duga | G. Guazzoni | F. Colombo | N. Buffi | R. Contieri | P. Avolio | V. Fasulo | A. Uleri | M. Lazzeri | R. Hurle | A. Saita | P. Casale | G. Lughezzani | R. Asselta | G. Soldà | P. Colombo | C. Chiereghin | A. Benetti | I. De Simone | C. Saitta | M. Corbetta
[1] A. Zvyagin,et al. Liquid Biopsy in Diagnosis and Prognosis of Non-Metastatic Prostate Cancer , 2022, Biomedicines.
[2] J. Thiery,et al. Isolation of Circulating Tumor Cells from Seminal Fluid of Patients with Prostate Cancer Using Inertial Microfluidics , 2022, Cancers.
[3] Chandrahas Koumar Ratnacaram,et al. Circulating metabolite biomarkers: a game changer in the human prostate cancer diagnosis , 2022, Journal of Cancer Research and Clinical Oncology.
[4] W. Oyen,et al. EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [177Lu]Lu-PSMA Radioligand Therapy. , 2022, European urology oncology.
[5] A. Jemal,et al. Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.
[6] M. Nowicki,et al. Clinical Relevance of Circulating Tumor Cells in Prostate Cancer Management , 2021, Biomedicines.
[7] A. Koyanagi,et al. Ejaculation Disorders in Male Patients with Cancer: A Systematic Review and Meta-Analysis of Prevalence , 2021, The Journal of urology.
[8] N. Salem,et al. Impact of active surveillance for prostate cancer on the risk of depression and anxiety , 2021, Scientific Reports.
[9] A. Minervini,et al. Alfuzosin for the medical treatment of benign prostatic hyperplasia and lower urinary tract symptoms: a systematic review of the literature and narrative synthesis , 2021, Therapeutic advances in urology.
[10] H. G. van der Poel,et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. , 2020, European urology.
[11] C. Sharpley,et al. Depression and prostate cancer: implications for urologists and oncologists , 2020, Nature Reviews Urology.
[12] P. Paterlini-Bréchot,et al. Clinical Impact of Circulating Tumor Cells in Patients with Localized Prostate Cancer , 2019, Cells.
[13] D. Leong,et al. Depression and prostate cancer: A focused review for the clinician. , 2019, Urologic oncology.
[14] S. Aedo,et al. 10 Year Biochemical Failure Free Survival of Men with CD82 Positive Primary Circulating Prostate Cells Treated by Radical Prostatectomy , 2018, Asian Pacific journal of cancer prevention : APJCP.
[15] G. Veronesi,et al. PD06-10 LIQUID BIOPSY BY PROSTATE-DERIVED TUMOR CELLS ENRICHED FROM SEMINAL FLUID (SF): THE SEMEN PROSTATE CANCER TUMOR ELEMENTS (SPECTRE) PROJECT. , 2018 .
[16] V. Velculescu,et al. Cancer DNA in the Circulation: The Liquid Biopsy. , 2017, JAMA.
[17] L. Egevad,et al. A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score. , 2016, European urology.
[18] B. Delahunt,et al. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System , 2015, The American journal of surgical pathology.
[19] R. Gardiner,et al. Seminal fluid: a useful source of prostate cancer biomarkers? , 2015, Biomarkers in medicine.
[20] H. Cho,et al. Silodosin for the treatment of clinical benign prostatic hyperplasia: safety, efficacy, and patient acceptability , 2014, Research and Reports in Urology.
[21] M. Carini,et al. Morbidity and psychological impact of prostate biopsy: the future calls for a change , 2014, Asian journal of andrology.
[22] Evyatar Marienberg. Traditional Jewish Sexual Practices and Their Possible Impact on Jewish Fertility and Demography* , 2013, Harvard Theological Review.
[23] N. Masumori,et al. Inhibition of Seminal emission is the main cause of anejaculation induced by a new highly selective alpha1A-blocker in normal volunteers. , 2008, The journal of sexual medicine.
[24] Donald Wlodkowic,et al. SYTO probes in the cytometry of tumor cell death , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[25] A. Bohnen,et al. Determinants of ejaculatory dysfunction in a community‐based longitudinal study , 2007 .
[26] E. Tippett,et al. Discrimination of live and early apoptotic mononuclear cells by the fluorescent SYTO 16 vital dye. , 2005, Journal of immunological methods.
[27] H. Ragde,et al. Method for identifying prostate cells in semen using flow cytometry , 1998, The Prostate.
[28] M. Lavin,et al. Abnormal prostatic cells in ejaculates from men with prostatic cancer--a preliminary report. , 1996, British journal of urology.
[29] A. Hirsh. Post-coital sperm retrieval could lead to the wider approval of assisted conception by some religions. , 1996, Human reproduction.
[30] H. Lilja. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. , 1985, The Journal of clinical investigation.
[31] L. Goulart,et al. Research landscape of liquid biopsies in prostate cancer. , 2019, American journal of cancer research.
[32] A. Tinker,et al. in Patients with Localized Prostate Cancer A Phase II Pharmacodynamic Study of Preoperative Figitumumab , 2012 .